Johnson & Johnson reported higher quarterly earnings on Tuesday as cost cuts offset weak sales of its drugs, devices and consumer products amid the economic downturn, but J & J; forecast 2009 earnings below expectations.
*For more on this story,
read the full Reuters article.
